Two disease-related pathways — inflammatory bowel disease (cfa05321; GATA3, TLR4) and cancer pathways (cfa05222; COL4A1, E2F3, RARB) — were also enriched. This evidence concerns the gene E2F3 and inflammatory bowel disease.